IO Biotech, Inc. (IOBT)
NASDAQ: IOBT · Real-Time Price · USD
1.890
+0.190 (11.18%)
Jul 16, 2025, 4:00 PM - Market closed
IO Biotech Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 |
---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 |
Cash & Equivalents | 37.09 | 60.03 | 143.19 | 142.59 | 211.53 | 3.41 | Upgrade |
Cash & Short-Term Investments | 37.09 | 60.03 | 143.19 | 142.59 | 211.53 | 3.41 | Upgrade |
Cash Growth | -68.57% | -58.08% | 0.42% | -32.59% | 6112.36% | -56.60% | Upgrade |
Other Receivables | 0.92 | 1.13 | 1.13 | 1.53 | 2.09 | 1.5 | Upgrade |
Receivables | 0.92 | 1.13 | 1.13 | 1.53 | 2.09 | 1.5 | Upgrade |
Prepaid Expenses | 0.96 | 1.12 | 1.35 | 1.72 | 3.2 | - | Upgrade |
Other Current Assets | 3.37 | 2.67 | 1.58 | 2.38 | 4.92 | 0.73 | Upgrade |
Total Current Assets | 42.34 | 64.95 | 147.26 | 148.22 | 221.74 | 5.64 | Upgrade |
Property, Plant & Equipment | 2.2 | 2.36 | 3.11 | 3.23 | 0.16 | - | Upgrade |
Other Long-Term Assets | 1.19 | 0.39 | 0.36 | 0.35 | 0.4 | 0.02 | Upgrade |
Total Assets | 45.74 | 67.7 | 150.72 | 151.81 | 222.29 | 5.65 | Upgrade |
Accounts Payable | 5.2 | 4.66 | 3.88 | 4 | 3.93 | 0.52 | Upgrade |
Accrued Expenses | 11.85 | 13.61 | 10.62 | 4.21 | 5.92 | 2.27 | Upgrade |
Current Portion of Leases | 0.74 | 0.72 | 0.66 | 0.52 | - | - | Upgrade |
Other Current Liabilities | 0.51 | 0.5 | 0.56 | 1.95 | 0.46 | 0.26 | Upgrade |
Total Current Liabilities | 18.29 | 19.49 | 15.72 | 10.68 | 10.31 | 3.05 | Upgrade |
Long-Term Leases | 1.03 | 1.2 | 1.84 | 2.28 | - | - | Upgrade |
Other Long-Term Liabilities | - | - | - | - | 0.06 | - | Upgrade |
Total Liabilities | 19.31 | 20.68 | 17.56 | 12.95 | 10.36 | 3.05 | Upgrade |
Common Stock | 0.07 | 0.07 | 0.07 | 0.03 | 0.03 | 0.03 | Upgrade |
Additional Paid-In Capital | 414.68 | 413.11 | 406.59 | 326.71 | 319.67 | 1.11 | Upgrade |
Retained Earnings | -381.73 | -359.31 | -263.82 | -177.74 | -106.28 | -38.4 | Upgrade |
Comprehensive Income & Other | -6.59 | -6.85 | -9.67 | -10.14 | -1.49 | 1.96 | Upgrade |
Total Common Equity | 26.42 | 47.02 | 133.16 | 138.85 | 211.92 | -35.3 | Upgrade |
Shareholders' Equity | 26.42 | 47.02 | 133.16 | 138.85 | 211.92 | 2.6 | Upgrade |
Total Liabilities & Equity | 45.74 | 67.7 | 150.72 | 151.81 | 222.29 | 5.65 | Upgrade |
Total Debt | 1.76 | 1.92 | 2.49 | 2.79 | - | - | Upgrade |
Net Cash (Debt) | 35.32 | 58.12 | 140.7 | 139.8 | 211.53 | 3.41 | Upgrade |
Net Cash Growth | -69.46% | -58.70% | 0.64% | -33.91% | 6112.36% | - | Upgrade |
Net Cash Per Share | 0.54 | 0.88 | 3.23 | 4.85 | 48.79 | 19.22 | Upgrade |
Filing Date Shares Outstanding | 65.88 | 65.88 | 65.88 | 28.82 | 28.82 | 0.18 | Upgrade |
Total Common Shares Outstanding | 65.88 | 65.88 | 65.88 | 28.82 | 28.82 | 0.18 | Upgrade |
Working Capital | 24.06 | 45.47 | 131.54 | 137.54 | 211.43 | 2.59 | Upgrade |
Book Value Per Share | 0.40 | 0.71 | 2.02 | 4.82 | 7.35 | -199.23 | Upgrade |
Tangible Book Value | 26.42 | 47.02 | 133.16 | 138.85 | 211.92 | -35.3 | Upgrade |
Tangible Book Value Per Share | 0.40 | 0.71 | 2.02 | 4.82 | 7.35 | -199.23 | Upgrade |
Machinery | 1.26 | 1.22 | 1.18 | 0.86 | 0.17 | - | Upgrade |
Updated May 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.